{"prompt": "['SPIMM-301 Version 4.0', '15 June 2018', 'APPENDIX 4. LIST OF CLINICAL LABORATORY TESTS TO BE', 'PERFORMED', 'Hematology:', 'Chemistry:', 'Haemoglobin', 'Sodium', 'Haematocrit', 'Potassium', 'Erythrocyte count (RBC)', 'Total bilirubin', 'MCH', 'Direct bilirubin', 'MCHC', 'Indirect bilirubin', 'MCV', 'Bicarbonate', 'RBC morphology', 'Alkaline phosphatase (ALK-P)', 'Leukocytes (WBC)', 'Alanine aminotransferase (ALT)', 'Neutrophils (ANC, segmented %)', 'Aspartate aminotransferase (AST)', 'Lymphocytes (absolute, %)', 'Blood urea nitrogen (BUN)', 'Monocytes (absolute, %)', 'Gamma-glutamyl transpeptidase (GGTP)', 'Eosinophils (absolute, %)', 'Creatine kinase (CK)', 'Basophils (absolute, %)', 'Creatinine', 'Platelets', 'LDH', 'Uric Acid', 'Urinalysis:', 'Phosphate', 'Color & Clarity', 'Total Protein', 'Specific Gravity', 'Globulin', 'pH', 'Magnesium', 'Protein', 'Calcium', 'Glucose', 'Glucose (non-fasting)', 'Ketones', 'Albumin', 'Bilirubin', 'Chloride', 'Urobilinogen', 'Triglycerides', 'Blood', 'Cholesterol', 'Nitrite', 'HDL', 'Leukocyte esterase', 'LDL', 'VLDL', 'Lactate', 'Immunogenicity sample (Baseline and', 'eGFR', 'Week 24 ONLY)', 'Stealth Bio Therapeutics Inc.', 'CONFIDENTIAL', '86']['SPIMM-301 Version 4.0', '15 June 2018', 'APPENDIX 5. COLUMBIA-SUICIDE SEVERITY RATING SCALE (C-', 'SSRS) \"BASELINE/SCREENING\"', 'Stealth Bio Therapeutics Inc.', 'CONFIDENTIAL', '87']['COLUMBIA-SUICIDE SEVERITY', 'RATING SCALE', '(C-SSRS)', 'Baseline/Screening Version', 'Version 1/14/09', 'Posner, K.; Brent, D.; Lucas, C.; Gould, M.; Stanley, B.; Brown, G.; Fisher, P.; Zelazny, J.;', 'Burke, A.; Oquendo, M.; Mann, J.', 'Disclaimer:', 'This scale is intended to be used by individuals who have received training in its administration. The questions contained in', 'the Columbia-Suicide Severity Rating Scale are suggested probes. Ultimately, the determination of the presence of suicidal', 'ideation or behavior depends on the judgment of the individual administering the scale.', 'Definitions of behavioral suicidal events in this scale are based on those used in The Columbia Suicide History Form,', 'developed by John Mann, MD and Maria Oquendo, MD, Conte Center for the Neuroscience of Mental Disorders', '(CCNMD), New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY, 10032. (Oquendo M. A.,', 'Halberstam B. & Mann J. J., Risk factors for suicidal behavior: utility and limitations of research instruments. In M.B. First', '[Ed.] Standardized Evaluation in Clinical Practice, pp. 103-130,2003.) -', 'For reprints of the C-SSRS contact Kelly Posner, Ph.D., New York State Psychiatric Institute, 105/ Riverside Drive, New', 'York, New York, 10032; inquiries and training requirements contact posnerk@nyspi.columbia.edu', 'C 2008 The Research Foundation for Mental Hygiene, Inc.', 'C-SSRS Baseline Screening - United States/English - Mapi.', 'C-SSRS-BaselineScreening_AU5.1_eng-USori.doc']\n\n###\n\n", "completion": "END"}